424 studies found for:    Wilson Disease
Show Display Options
Rank Status Study
21 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
22 Recruiting Tissue Collection for Studies of Lymph Cancer
Conditions: Hodgkin Disease;   Lymphoma, Non-Hodgkin;   Multiple Myeloma;   Lymphomatoid Granulomatosis;   Leukemia-Lymphoma, Adult T-Cell
Intervention:
23 Completed Reducing Alcohol Use & Post-traumatic Stress Disorder (PTSD) With Cognitive Restructuring & Experiential Acceptance
Conditions: Alcoholism;   Stress Disorders, Post-Traumatic
Interventions: Behavioral: Experiential acceptance;   Behavioral: Cognitive restructuring;   Other: No-intervention control: Nutrition information
24 Unknown  Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Conditions: Adenocarcinoma of the Colon;   Stage III Colon Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: cetuximab
25 Recruiting Phase I/IIa Study of StarGen in Patients With Stargardt Macular Degeneration
Condition: Stargardt Disease
Intervention: Genetic: StarGen
26 Recruiting EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma
Condition: Lymphoma, Mantle Cell
Interventions: Drug: bortezomib;   Other: clinical observation
27 Recruiting A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder
Condition: Binge-Eating Disorder
Interventions: Drug: Methylphenidate;   Behavioral: Cognitive Behavioral Therapy
28 Completed A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
Conditions: Memory Disorders, Age-Related;   Retention Disorders, Cognitive
Interventions: Drug: EGb 761®  (Tanakan®);   Other: Placebo
29 Not yet recruiting Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Dyspnoea;   Anxiety;   Depression
Intervention:
30 Not yet recruiting Virtual Reality Based Cue-exposure Treatment for Bulimia Nervosa
Conditions: Bulimia Nervosa;   Binge-Eating Disorder;   Binge Eating
Interventions: Behavioral: VR based cue-exposure booster sessions;   Behavioral: Cognitive-behavioral booster sessions
31 Active, not recruiting
Has Results
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Radiation: Standard fractionation RT;   Radiation: Accelerated fractionation radiation therapy;   Procedure: Conventional surgery for select patients
32 Unknown  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
33 Not yet recruiting Study of Lamotrigine to Treat Ménière's Disease
Conditions: Meniere's Disease;   Ménière's Vertigo;   Vertigo, Intermittent;   Vertigo, Aural
Interventions: Drug: Lamotrigine;   Drug: Placebo
34 Recruiting Treatment and Natural History Study of Lymphomatoid Granulomatosis
Condition: Lymphomatoid Granulomatosis
Intervention:
35 Active, not recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Conditions: Hereditary Non-polyposis Colon Cancer;   Mucinous Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Colon;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer
Interventions: Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Biological: bevacizumab;   Other: laboratory biomarker analysis
36 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
37 Active, not recruiting Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome;   Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Recurrent Adult Acute Myeloid Leukemia;   Refractory Anemia With Excess Blasts in Transformation
Interventions: Drug: tipifarnib;   Procedure: clinical observation
38 Completed
Has Results
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: cyclosporine ophthalmic emulsion 0.05%, artificial tears
39 Recruiting Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome
Conditions: Conditions Influencing Health Status;   Healthy;   Prostate Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: transrectal prostate biopsy
40 Completed Frequency Analysis of Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years